All News about Exelixis Inc
![](https://mms.businesswire.com/media/20230820936777/en/1870961/22/Exelixis_Logo_RGB_2023.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230816111238_3-strong-biotech-performers-to-watch-as-sector-nea.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Expectations for Exelixis's Future
August 02, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://g.foolcdn.com/editorial/images/740610/patient-sitting-on-hospital-bed.jpg)
![](/next-assets/images/schema-image-default.png)
8 Analysts Have This to Say About Exelixis
May 10, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230801307436/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](/next-assets/images/schema-image-default.png)
Exelixis: Q1 Earnings Insights
May 09, 2023
Via Benzinga
![](https://www.marketbeat.com/logos/articles/med_20230727124843_7-best-cancer-stocks-to-invest-in-now.jpg)
![](https://mms.businesswire.com/media/20230721235791/en/1847444/22/Exelixis_Logo_RGB_2023.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://mms.businesswire.com/media/20230718950128/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://g.foolcdn.com/editorial/images/736704/two-hundred-dollars-cash-money-invest-retire-stocks-getty.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230530005657/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://g.foolcdn.com/editorial/images/734072/physician-talking-to-patient.jpg)
![](https://g.foolcdn.com/editorial/images/733332/cancer-patient-flexing-muscle.jpg)
![](https://g.foolcdn.com/editorial/images/732744/group-of-people-laughing-and-high-fiving.jpeg)
![](https://www.marketbeat.com/logos/articles/med_20230517121722_analysts-say-these-2-mid-cap-biotechs-have-2x-pote.jpg)
![](https://g.foolcdn.com/editorial/images/731785/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
![](https://mms.businesswire.com/media/20230509005349/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/08/exel.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230507005032/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.